The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Heparanases and tumor metastasis
Abstract
The successful penetration of endothelial basement membranes is an important process in the formation of hematogenous tumor metastases. Heparan sulfate (HS) proteoglycan is a major constituent of endothelial basement membranes, and we have found that HS‐degradative activities of metastatic B16 melanoma sublines correlate with their lung‐colonizing potentials. The melanoma HS‐degrading enzyme is a unique endo‐β‐D‐glucuronidase (heparanase) that cleaves HS at specific intrachain sites and is detectable in a variety of cultured human malignant melanomas. The treatment of B16 melanoma cells with heparanase inhibitors that have few other biological activities, such as N‐acetylated N‐desulfated heparin, results in significant reductions in the numbers of experimental lung metastases in syngeneic mice, indicating that heparanase plays an important role in melanoma metastasis. HS‐degrading endoglycosidases are not tumor‐specific and have been found in several normal tissues and cells. There are at least three types of endo‐β‐D‐glucuronidases based on their substrate specificities. Melanoma heparanase, an M r ∼96,000 enzyme with specificity for β‐D‐glucuronosyl‐N‐acetylglucosaminyl linkages in HS, is different from platelet and mastocytoma endoglucuronidases. Elevated levels of heparanase have been detected in sera from metastatic tumor‐bearing animals and malignant melanoma patients, and a correlation exists between serum heparanase activity and extent of metastases. The results suggest that heparanase is potentially a useful marker for tumor metastasis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Plasminogen Activators, Tissue Degradation, and Cancer
(1985) · Advances in Cancer Research · doi:10.1016/s0065-230x(08)60028-7 · Cited by 2,535
Gold, P., & Freedman, S. O. (1965) · The Journal of Experimental Medicine · doi:10.1084/jem.121.3.439 · Cited by 2,310
Metastatic potential correlates with enzymatic degradation of basement membrane collagen
Liotta, L. A., Tryggvason, K., Garbisa, S., Hart, I., Foltz, C. M., & Shafie, S. (1980) · Nature · doi:10.1038/284067a0 · Cited by 1,768
Alpha-Fetoprotein in Ontogenesis and its Association with Malignant Tumors
(1971) · Advances in Cancer Research · doi:10.1016/s0065-230x(08)60523-0 · Cited by 877
Kanwar, Y. S., Linker, A., & Farquhar, M. G. (1980) · The Journal of cell biology · doi:10.1083/jcb.86.2.688 · Cited by 647
Nicolson, G. L. (1982) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/0304-419x(82)90020-8 · Cited by 560
Self-citationBiochemistry and Metabolism of Basement Membranes
Kefalides, N. A., Alper, R., & Clark, C. C. (1979) · International Review of Cytology · doi:10.1016/s0074-7696(08)61998-1 · Cited by 460
Liotta, L. A., Abe, S., Robey, P. G., & Martin, G. R. (1979) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.76.5.2268 · Cited by 449
Structure and Biological Activity of Heparin
Casu, B. (1985) · Advances in Carbohydrate Chemistry and Biochemistry · doi:10.1016/s0065-2318(08)60067-0 · Cited by 428
Ginsburg, V., & Robbins, P. W. (1981) · Medical Entomology and Zoology · Cited by 426
Cited by
Mammalian heparanase: Gene cloning, expression and function in tumor progression and metastasis
Vlodavsky, I., Friedmann, Y., Elkin, M., Aingorn, H., Atzmon, R., Ishai-Michaeli, R., Bitan, M., Pappo, O., Peretz, T., Michal, I., et al. (1999) · Nature Medicine · doi:10.1038/10518 · Cited by 803
Johnson, G. B., Brunn, G. J., Kodaira, Y., & Platt, J. L. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.10.5233 · Cited by 648
Molecular properties and involvement of heparanase in cancer metastasis and angiogenesis
Vlodavsky, I., & Friedmann, Y. (2001) · Journal of Clinical Investigation · doi:10.1172/jci13662 · Cited by 618
Axis of evil: molecular mechanisms of cancer metastasis
Bogenrieder, T., & Herlyn, M. (2003) · Oncogene · doi:10.1038/sj.onc.1206757 · Cited by 593
Regulation, function and clinical significance of heparanase in cancer metastasis and angiogenesis
Ilan, N., Elkin, M., & Vlodavsky, I. (2006) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2006.06.004 · Cited by 524
Cloning of mammalian heparanase, an important enzyme in tumor invasion and metastasis
Hulett, M. D., Freeman, C., Hamdorf, B. J., Baker, R. T., Harris, M. J., & Parish, C. R. (1999) · Nature Medicine · doi:10.1038/10525 · Cited by 518
Ferretti, C., Bruni, L., Dangles-Marie, V., Pecking, A. P., & Bellet, D. (2006) · Human Reproduction Update · doi:10.1093/humupd/dml048 · Cited by 509
The role of heparan sulphate in inflammation
Parish, C. R. (2006) · Nature Reviews Immunology · doi:10.1038/nri1918 · Cited by 495
Noonan, D. M., Fulle, A., Valente, P., Cai, S., Horigan, E., Sasaki, M., Yamada, Y., & Hassell, J. R. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)54445-8 · Cited by 449
Nicolson, G. L. (1988) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/0304-419x(88)90010-8 · Cited by 399
Self-citationWelch, D. R., Fabra, A., & Nakajima, M. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.19.7678 · Cited by 392
Self-citationEnzymatic Degradation of GlycosaminogIycans
Ernst, S., Langer, R., Cooney, C. L., & Sasisekharan, R. (1995) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.3109/10409239509083490 · Cited by 387
The role of proteolytic enzymes in cancer invasion and metastasis
Duffy, M. J. (1992) · Clinical & Experimental Metastasis · doi:10.1007/bf00132746 · Cited by 373
Pharmacology of Heparin and Related Drugs
Mulloy, B., Hogwood, J., Gray, E., Lever, R., & Page, C. P. (2016) · Pharmacological Reviews · doi:10.1124/pr.115.011247 · Cited by 341
Heparanase, Hyaluronan, and CD44 in Cancers: A Breast Carcinoma Perspective
Götte, M., & Yip, G. W. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-1464 · Cited by 340
Novel drug development opportunities for heparin
Lever, R., & Page, C. P. (2002) · Nature Reviews Drug Discovery · doi:10.1038/nrd724 · Cited by 328
Heparanase as mediator of angiogenesis: mode of action
Elkin, M., Ilan, N., Ishai-Michaeli, R., Friedmann, Y., Papo, O., Pecker, I., & Vlodavsky, I. (2001) · The FASEB Journal · doi:10.1096/fj.00-0895fje · Cited by 310
The Complex Effects of Heparins on Cancer Progression and Metastasis in Experimental Studies
Smorenburg, S. M., & Van Noorden, C. J. F. (2001) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01481-9 · Cited by 294
Extracellular sequestration and release of fibroblast growth factor: a regulatory mechanism?
Vlodavsky, I., Bar-Shavit, R., Ishar-Michael, R., Bashkin, P., & Fuks, Z. (1991) · Trends in Biochemical Sciences · doi:10.1016/0968-0004(91)90102-2 · Cited by 283
Vlodavsky, I., Ishai‐Michaeli, R., Bashkin, P., Levi, E., Korner, G., Bar‐Shavit, R., Fuks, Z., & Klagsbrun, M. (1991) · Journal of Cellular Biochemistry · doi:10.1002/jcb.240450208 · Cited by 265
Heparan sulfate proteoglycans in invasion and metastasis
Sanderson, R. D. (2001) · Seminars in Cell & Developmental Biology · doi:10.1006/scdb.2000.0241 · Cited by 262
Stepping out of the flow: capillary extravasation in cancer metastasis
Miles, F. L., Pruitt, F. L., van Golen, K. L., & Cooper, C. R. (2008) · Clinical & Experimental Metastasis · doi:10.1007/s10585-007-9098-2 · Cited by 262
Substrate Specificity of Heparanases from Human Hepatoma and Platelets
Pikas, D. S., Li, J.-P., Vlodavsky, I., & Lindahl, U. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.30.18770 · Cited by 261
Joyce, J. A., Freeman, C., Meyer-Morse, N., Parish, C. R., & Hanahan, D. (2005) · Oncogene · doi:10.1038/sj.onc.1208602 · Cited by 163
Miao, H., Ishai‐Michaeli, R., Peretz, T., & Vlodavsky, I. (1995) · Journal of Cellular Physiology · doi:10.1002/jcp.1041640306 · Cited by 49
Metadata
- Authors
- Nakajima, M., Irimura, T., & Nicolson, G. L.
- Venue
- Journal of Cellular Biochemistry
- Publisher
- Wiley
- Published
- 1988-02
- Volume
- 36
- Issue
- 2
- Pages
- 157-167
- ISSN
- 0730-2312 (ISSN-L)
- 1097-4644
- OpenAlex
- W2091857312
- Cited by
- 305
- References
- 38
- FWCI
- 4.81
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.